The case for & against
Bull & Bear analysis
America's Gold and Silver Corp. (NASDAQ: USAS) is an emerging player in the mining sector, focusing primarily on silver and antimony production through its operations in the United States and Mexico. The company is strategically positioned within the precious metals market, particularly emphasizing resource growth at its Galena Complex and COSLA operations. It targets high-value silver production and is leveraging its assets to capitalize on the rising demand for silver and critical minerals amidst geopolitical pressures.
Bull says
- ↑Q4 2025 silver production surged 52% to 2.65M oz, boosting cash flows.
- ↑Q3 2025 revenue rose 37% YoY to $30.6M, driven by higher metal prices.
- ↑Allocated $15–20M for exploration to expand high-grade resources.
- ↑As one of few US antimony producers, benefits from critical minerals demand.
- ↑Median analyst PT $9.75 implies 155% upside; 8 buy ratings.
- ↑High growth and momentum factors with strong liquidity support trading.
Bear says
- ↓Q1 2025 net loss of $19M and high G&A expenses pressure profits.
- ↓Elevated leverage risk with $90–120M capex plan may strain cash flows.
- ↓Silver drives 87% of revenue, exposing USAS to price volatility.
- ↓Negative revisions and downgrades signal waning analyst sentiment.
- ↓Operational shift to long-hole stoping risks delays and cost overruns.
- ↓Weak profitability and earnings yield factors suggest limited return potential.
Investment themes with USAS
Earnings Call · Q1 2025 · Mgmt. Guidance
Transcript signals
Bull points
- Being part of the SIL underscores our growing prominence as a silver-focused producer and validates the strategic progress we've made.
- Looking ahead to later this year, we see strong potential for inclusion in the VanEck Junior Gold Miners ETF, or the GDXJ, which would be another big milestone for our company.
- since closing the Galena CompEx consolidation transaction in December, we've significantly expanded our investor base, with America's percentage of tightly held shares growing from about 8% to over 60%, with large institutions such as Merck, Delbruck, Conwave, CQS, and McKenzie building substantial positions.
Bear points
- We recorded a net loss of $19 million for Q1 2025 compared to a net loss of $16 million last year. The increased loss was primarily due to the impact of metal prices on our metal-based liabilities and higher corporate G&A expenses.
- Adjusted earnings for the quarter were a loss of $11.5 million, and adjusted EBITDA was a loss of $5.5 million.